Pharmacyclics announces positive results from IMBRUVICA Phase II study in WM patients

Posted in: Drug Trial News | Medical Condition News

Tags: Anemia, Antibody, Anticoagulant, Atrial Fibrillation, Blood, Blood Cancer, Bone, Bone Marrow, Cancer, Carcinomas, Cell, Chromosome, Chromosome 17, Chronic Lymphocytic Leukemia, Clinical Trial, Diarrhea, Drugs, Dyspnea, Fatigue, Fever, Gastrointestinal Bleeding, Genetic, Genetics, Growth Hormone, Hematology, Hematuria, Hormone, Immunoglobulin, Leukemia, Lymphoma, Mantle Cell Lymphoma, Medical School, Melanoma, Musculoskeletal, Nausea, Neutropenia, Pain, Pregnancy, Protein, Respiratory, Skin Cancer, Thrombocytopenia, Tumor, Tyrosine